Freja eID to drop Swedish driver’s licenses, tax agency ID cards from supported IDs after Dec. 21, 2026
Bitget2026/10/08 14:04Freja will stop accepting non-biometric Swedish driver’s licenses, Swedish Tax Agency ID cards for onboarding from Dec. 21, 2026. Shift reflects tighter identity-security requirements, raising compliance thresholds for customer verification across Freja’s registration process. In-person checks at agents will no longer grant Freja+ from that date, moving upgrades to a fully digital biometric-ID process. Users registered with those IDs without Freja+ must complete an on-site security check by Dec. 20, 2026, or add biometric ID later. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Freja eID Group AB published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Freja will stop accepting non-biometric Swedish driver’s licenses, Swedish Tax Agency ID cards for onboarding from Dec. 21, 2026.
- Shift reflects tighter identity-security requirements, raising compliance thresholds for customer verification across Freja’s registration process.
- In-person checks at agents will no longer grant Freja+ from that date, moving upgrades to a fully digital biometric-ID process.
- Users registered with those IDs without Freja+ must complete an on-site security check by Dec. 20, 2026, or add biometric ID later.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
